1 matches for your search in the start-up spotlight
rssExeliom Biosciences is a clinical-stage biopharmaceutical company specialized in the development of microbiome-based immunotherapies with a mission to bring innovation to the treatment of inflammatory bowel diseases, cancer, and infectious diseases. Its lead asset, EXL01, a rationally selected, ...